Stocktoria

Edgewise Therapeutics, Inc. EWTX

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-03-26

Edgewise Therapeutics, Inc. statistics & valuation

Market cap$4.5B
P / B8.5×
Return on equity-32.1%
Return on capital-36.4%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202020212022202320242025
Operating margin (%)
202020212022202320242025
Return on equity (%)
-15.60% -19.50% -31.40% -29.10% -32.10% 202020212022202320242025
Shares outstanding
1.0M 49.5M 63.3M 70.5M 94.8M 106.2M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-13.10% -15.00% -18.40% -29.50% -27.50% -30.40% 202020212022202320242025
Free cash flow margin (%)
202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
-$23.17 -$1.14 -$1.26 -$1.57 -$1.45 -$1.63 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Return on assets-30.4%-27.5%-29.5%-18.4%-15.0%-13.1%
Return on equity-32.1%-29.1%-31.4%-19.5%-15.6%51.2%
Current ratio19.8519.9319.5021.5326.9729.86

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.